Fujifilm pivots to biopharma CDMO and semiconductors, eyes Spain expansion

Fujifilm Europe's president identifies biopharmaceutical CDMO and semiconductor materials as key growth drivers, signaling a strategic shift from legacy film business. The company advocates for Spain as a strategic market, likely for manufacturing or R&D investment. This reflects a broader corporate transformation but has limited immediate market impact.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works